Oman vs Sri Lanka: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Oman rank
1st
Sri Lanka rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Sri Lanka
How they compare
Oman currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 9 times across 18 shared years of data; in 2003 it was Oman ahead.
Oman ranks 1st and Sri Lanka ranks 1st of 144 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 83.3% | 16.7% | Oman |
| 2010s | 93.1% | 81.1% | 12.0% | Oman |
| 2020s | 91.4% | 67.0% | 24.4% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Sri Lanka?
- Oman, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Sri Lanka?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sri Lanka?
- 18 years are reported by both, from 2003 to 2024.
- How do Oman and Sri Lanka rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Sri Lanka ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.